These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 389502)
61. Factor VIII complex in uraemia and effects of haemodialysis. Turney JH; Woods HF; Fewell MR; Weston MJ Br Med J (Clin Res Ed); 1981 May; 282(6277):1653-6. PubMed ID: 6786417 [TBL] [Abstract][Full Text] [Related]
62. In vitro prostacyclin production in the hemolytic-uremic syndrome. Siegler RL; Smith JB; Lynch MB; Mohammad SF West J Med; 1986 Feb; 144(2):165-8. PubMed ID: 3754077 [TBL] [Abstract][Full Text] [Related]
63. The clinical significance of prostaglandins and thromboxane as mediators of septic shock. Oettinger W; Berger D; Beger HG Klin Wochenschr; 1987 Jan; 65(2):61-8. PubMed ID: 3550266 [TBL] [Abstract][Full Text] [Related]
64. Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients. Kuźniewski M; Sułowicz W; Lisiewicz J Int Urol Nephrol; 1991; 23(1):89-96. PubMed ID: 1938222 [TBL] [Abstract][Full Text] [Related]
65. Vascular factors in the pathogenesis of uraemic bleeding. Remuzzi G; Bertani T; Livio M; Cavenaghi AE; Mysliwiec M; Marchesi D; Donati MC; de Gaetano G; Mecca G Proc Eur Dial Transplant Assoc; 1978; 15():449-55. PubMed ID: 368787 [TBL] [Abstract][Full Text] [Related]
66. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis. Ylikorkala O; Huttunen K; Järvi J; Viinikka L Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193 [TBL] [Abstract][Full Text] [Related]
67. Prostacyclin-like activity and bleeding in renal failure. Remuzzi G; Cavenaghi AE; Mecca G; Donati MB; de Gaetano G Lancet; 1977 Dec; 2(8050):1195-7. PubMed ID: 73900 [TBL] [Abstract][Full Text] [Related]
68. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure. Kyrle PA; Stockenhuber F; Brenner B; Gössinger H; Korninger C; Pabinger I; Sunder-Plassmann G; Balcke P; Lechner K Thromb Haemost; 1988 Oct; 60(2):205-8. PubMed ID: 2975407 [TBL] [Abstract][Full Text] [Related]
69. Bleeding in renal failure: a possible role of vascular prostacyclin (PGI2). Remuzzi G; Marchesi D; Cavenaghi AE; Livio M; Donati MB; de Gaetano G; Mecca G Clin Nephrol; 1979 Sep; 12(3):127-31. PubMed ID: 389502 [TBL] [Abstract][Full Text] [Related]
70. Treatment of bleeding in dialysis patients. Galbusera M; Remuzzi G; Boccardo P Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008 [TBL] [Abstract][Full Text] [Related]
71. Studies on the biological balance between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction. Jørgensen KA Dan Med Bull; 1982 May; 29(4):169-97. PubMed ID: 6286257 [No Abstract] [Full Text] [Related]
72. Prostacyclin: its biosynthesis, actions, and clinical potential. Dusting GJ; Moncada S; Vane JR Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():59-106. PubMed ID: 6216790 [No Abstract] [Full Text] [Related]
73. Prostacyclin in physiology and pathophysiology. Vane JR; Bunting S; Moncada S Int Rev Exp Pathol; 1982; 23():161-207. PubMed ID: 6806207 [No Abstract] [Full Text] [Related]
74. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]